SynthesisInternational journal of clinical pharmacy2025
Efficacy and safety of IL-23p19 antagonists versus placebo in inflammatory bowel disease: a systematic review and meta‑analysis of randomized controlled trials.
Xi-Yuan Peng et al.PubMed ↗Publisher ↗
No numbers read from the abstract.